These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 7631125

  • 1. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
    Renz A, Trees AJ, Achu-Kwi D, Edwards G, Wahl G.
    Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
    [Abstract] [Full Text] [Related]

  • 2. Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.
    Boussinesq M, Enyong P, Chounna-Ndongmo P, Njouendou AJ, Pion SD, Rech A, Roberge C, Gaudriault G, Wanji S.
    Parasite; 2020 Mar; 27():36. PubMed ID: 32420864
    [Abstract] [Full Text] [Related]

  • 3. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD, Grout L, Kamgno J, Nana-Djeunga H, Boussinesq M.
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [Abstract] [Full Text] [Related]

  • 4. The entry of ivermectin and suramin into Onchocerca ochengi nodules.
    Cross HF, Bronsvoort BM, Wahl G, Renz A, Achu-Kwi D, Trees AJ.
    Ann Trop Med Parasitol; 1997 Jun; 91(4):393-401. PubMed ID: 9290846
    [Abstract] [Full Text] [Related]

  • 5. Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control.
    Schulz-Key H, Karam M, Prost A.
    Trop Med Parasitol; 1985 Dec; 36(4):244-8. PubMed ID: 4089476
    [Abstract] [Full Text] [Related]

  • 6. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
    Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, Ahmed K, Boatin BA, Boakye DA, Edwards G.
    Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
    [Abstract] [Full Text] [Related]

  • 7. Animal models--Onchocerca ochengi and the development of chemotherapeutic and chemoprophylactic agents for onchocerciasis.
    Trees AJ, Wood VL, Bronsvoort M, Renz A, Tanya VN.
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S175-9. PubMed ID: 9861291
    [No Abstract] [Full Text] [Related]

  • 8. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
    Tchakouté VL, Bronsvoort M, Tanya V, Renz A, Trees AJ.
    Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
    [Abstract] [Full Text] [Related]

  • 9. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
    Mbah GE, Ayiseh RB, Cho-Ngwa F.
    BMC Infect Dis; 2016 Aug 11; 16(1):404. PubMed ID: 27515037
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of implanted male Onchocerca gibsoni in mice as a screen for macrofilaricides against Onchocerca volvulus.
    Vankan DM, Copeman DB, Novak M.
    Trop Med Parasitol; 1988 Dec 11; 39 Suppl 4():472-4. PubMed ID: 3227248
    [Abstract] [Full Text] [Related]

  • 11. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
    Duke BO, Zea-Flores G, Muñoz B.
    Trop Med Parasitol; 1991 Sep 11; 42(3):175-80. PubMed ID: 1801140
    [Abstract] [Full Text] [Related]

  • 12. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
    Mössinger J, Schulz-Key H, Dietz K.
    Trop Med Parasitol; 1988 Dec 11; 39(4):313-6. PubMed ID: 3067322
    [Abstract] [Full Text] [Related]

  • 13. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
    Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, Rascón AA, Tricoche N, Samje M, Bell A, Suzuki B, Lim KC, Supakorndej N, Supakorndej P, Wolfe AR, Knudsen GM, Chen S, Wilson C, Ang KH, Arkin M, Gut J, Franklin C, Marcellino C, McKerrow JH, Debnath A, Sakanari JA.
    PLoS Negl Trop Dis; 2015 Feb 11; 9(2):e0003534. PubMed ID: 25700363
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
    Awadzi K, Opoku NO, Attah SK, Addy ET, Duke BO, Nyame PK, Kshirsagar NA.
    Ann Trop Med Parasitol; 1997 Apr 11; 91(3):281-96. PubMed ID: 9229021
    [Abstract] [Full Text] [Related]

  • 15. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K, Dadzie KY, Shulz-Key H, Haddock DR, Gilles HM, Aziz MA.
    Ann Trop Med Parasitol; 1985 Feb 11; 79(1):63-78. PubMed ID: 3838638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
    Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT.
    Trans R Soc Trop Med Hyg; 1999 Feb 11; 93(2):189-94. PubMed ID: 10450448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.